Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.

Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR.

J Exp Med. 2008 Apr 14;205(4):799-810. doi: 10.1084/jem.20071258. Epub 2008 Apr 7.

2.

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion.

Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger D, Nussenblatt RB, Caspi RR.

J Immunol. 2008 Apr 15;180(8):5167-71.

3.

Activation of natural killer T cells by glycolipids.

Tupin E, Kronenberg M.

Methods Enzymol. 2006;417:185-201. Review.

PMID:
17132506
4.

Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands.

Tsuji M.

Cell Mol Life Sci. 2006 Aug;63(16):1889-98. Review.

PMID:
16794785
5.

Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity.

Grajewski RS, Silver PB, Agarwal RK, Su SB, Chan CC, Liou GI, Caspi RR.

J Exp Med. 2006 Apr 17;203(4):851-6. Epub 2006 Apr 3.

6.

Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.

Miyake S, Yamamura T.

Curr Drug Targets Immune Endocr Metabol Disord. 2005 Sep;5(3):315-22. Review.

PMID:
16178791
7.

Recognition of bacterial glycosphingolipids by natural killer T cells.

Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M.

Nature. 2005 Mar 24;434(7032):520-5.

8.

Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts.

Novak J, Beaudoin L, Griseri T, Lehuen A.

J Immunol. 2005 Feb 15;174(4):1954-61.

9.

Rodent models of experimental autoimmune uveitis.

Agarwal RK, Caspi RR.

Methods Mol Med. 2004;102:395-419.

PMID:
15286397
10.

NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease.

Yamamura T, Miyamoto K, Illés Z, Pál E, Araki M, Miyake S.

Curr Top Med Chem. 2004;4(5):561-7. Review.

PMID:
14965307
11.

An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms.

Avichezer D, Grajewski RS, Chan CC, Mattapallil MJ, Silver PB, Raber JA, Liou GI, Wiggert B, Lewis GM, Donoso LA, Caspi RR.

J Exp Med. 2003 Dec 1;198(11):1665-76.

13.

CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site.

Nakamura T, Sonoda KH, Faunce DE, Gumperz J, Yamamura T, Miyake S, Stein-Streilein J.

J Immunol. 2003 Aug 1;171(3):1266-71.

14.

Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.

Furlan R, Bergami A, Cantarella D, Brambilla E, Taniguchi M, Dellabona P, Casorati G, Martino G.

Eur J Immunol. 2003 Jul;33(7):1830-8.

15.

Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.

Wilson SB, Delovitch TL.

Nat Rev Immunol. 2003 Mar;3(3):211-22. Review.

PMID:
12658269
16.
17.

Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice.

Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, Lassmann H, Herbelin A, Lehuen A, Liblau RS.

J Immunol. 2002 Jun 15;168(12):6007-11.

18.

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

Singh AK, Wilson MT, Hong S, Olivares-Villagómez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L.

J Exp Med. 2001 Dec 17;194(12):1801-11.

19.

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis.

Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V.

J Exp Med. 2001 Dec 17;194(12):1789-99.

20.

Array-based ELISAs for high-throughput analysis of human cytokines.

Moody MD, Van Arsdell SW, Murphy KP, Orencole SF, Burns C.

Biotechniques. 2001 Jul;31(1):186-90, 192-4.

PMID:
11464511

Supplemental Content

Support Center